Highlights from IAS 2023
IAS 2023 brought together civil society, advocates, policy makers, donors, and scientists to share the latest HIV scientific findings and discuss where advocacy is needed to both advance research and ensure equity informs every aspect of the development process, from basic science to delivering new interventions. Read on for highlights from the conference. AVAC at…
From Prescription to Patient: The lifecycle of cabotegravir for PrEP
Long-acting injectable cabotegravir (CAB) for PrEP was approved by US FDA in December 2021, and the medication has been endorsed in several guidelines. It’s considered a game changer for providers and organizations to serve certain populations in need of HIV prevention for which daily oral PrEP has been suboptimal. However, the number of current CAB…
The Catalyst Study: Catalyzing access to new prevention products to stop HIV
This MOSAIC blogpost explores the launch of Catalyzing Access to New Prevention Products to Stop HIV (CATALYST). Read the full issue of the MOSAIC blog, here.
MOSAIC Blog: Positioning PrEP for Success: Six Key Lessons
This MOSAIC blogpost explores lessons learned in the failures of oral PrEP, and what can be learned when deploying multi-product PrEP portfolios. Read the full issue of the MOSAIC blog, here.
New Issue of PxWire: A look at where we are in HIV prevention
AVAC’s new issue of PxWire is here and shares the latest PrEP updates including new data from the PrEP Tracker, the HIV prevention pipeline, the prevention playlist and more! Check out the full issue here.
MOSAIC Blog: Celebrating one year of MOSAIC’s next gen
This month marks the first anniversary of the formation of MOSAIC’s NextGen Squad. The NextGen Squad is a team of paid youth advocates under the age of 30 who shape, influence, and participate in a variety of project activities. Read the full issue of the MOSAIC blog, here.
Dapivirine Vaginal Ring Shows Comparable HIV Risk Rate With Oral PrEP
This aidsmap article shares data from the 2023 Interest Conference in Zimbabwe on the dapivirine vaginal ring showing a similar rate of new HIV acquisitions between women using the ring and oral PrEP. Read the full story here.
Highlights from CROI 2023
The 30th Conference on Retroviruses and Opportunistic Infections (CROI) showed an energized field- with scientific advances galvanizing research across a host of disease areas. Click here to read AVAC’s roundup of CROI 2023 and learn about new interventions for sexually transmitted infections (STIs), expanding evidence for widespread use of long-acting products for HIV prevention, pipeline…
A Shot in the Arm Podcast: CAB for PrEP for African Girls and Women
This episode of A Shot in the Arm Podcast, recorded live at CROI 2023, features Ben Plumley and Yvette Raphael, from Advocates for the Prevention of HIV in Africa (APHA), in conversation with Dr. Kimberly Smith, the Head of Research and Development for ViiV Healthcare, makers of Cabotegravir (CAB) for PrEP, on what’s needed to…
The Gen-N Campaign: Young people lead the way to an HIV-free Nigeria
In December 2022, the Nigerian National Agency for the Control of AIDS (NACA), in partnership with MOSAIC, launched the country’s first-ever national youth-focused HIV prevention campaign: Generation-Negative, or “Gen-N.” Visit the MOSAIC blog to learn more about the campaign, how it was developed, and what’s next.